Macrogol 4000 Zydus (Macrogol 4000)

The active ingredient, macrogol 4000, is a high‑molecular‑weight polyethylene glycol that is not absorbed from the gut. It binds water molecules and retains them in the bowel, creating an osmotic gradient that softens stool and stimulates peristalsis, facilitating easier evacuation.

The appropriate dose of Macrogol 4000 Zydus is individualized and set by a qualified healthcare professional based on the patient’s age, severity of constipation, renal function, and overall clinical condition. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Macrogol 4000 in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing it to pregnant or nursing women. Consultation with a physician is essential to determine whether it is appropriate in these situations.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Macrogol 4000 Zydus. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Unlike stimulant laxatives, macrogol 4000 is a non‑stimulant osmotic agent that works by retaining water in the bowel rather than directly stimulating intestinal muscles. This generally results in a gentler effect with fewer cramping side effects, making it suitable for long‑term use and for patients who need a milder approach.

Store Macrogol 4000 Zydus at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and extreme temperatures to maintain its stability and efficacy.

Macrogol 4000 Zydus is taken orally, usually dissolved in a specified amount of water or another suitable liquid as directed by the prescriber. The mixture should be consumed promptly after preparation, and patients should follow the dosage instructions provided by their healthcare professional.

Serious risks, although rare, include severe electrolyte imbalance, marked dehydration and allergic reactions such as rash, swelling or difficulty breathing. Patients experiencing any of these symptoms should seek immediate medical attention and discontinue the product until evaluated by a healthcare professional.

Macrogol 4000 Zydus should be avoided in individuals with known hypersensitivity to macrogol or any of its excipients, in patients with intestinal obstruction or perforation, and in those with severe renal impairment unless specifically advised by a physician.